"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"
N/A
This is a monocentric, prospective, observational study that will be conduc...
Status
Completed
Location
ASST Monza
Start Date
2019-12-12
Trial ID
NCT04996394
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
PHASE4
The purpose of this trial is to evaluate the safety and efficacy of Sugamma...
Assessment of the PEEP Responsiveness to Titrate End-expiratory Pressure and of the Need for Muscle Relaxation During Prone Positioning in Moderate-to-severe Acute Respiratory Distress Syndrome: A Master Protocol
NA
Despite best supportive care, mortality of the Acute Respiratory Distress S...